We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
+12.14%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
–
AUM
$306M
AUM Growth
+$39.6M
Cap. Flow
+$9.55M
Cap. Flow %
3.12%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$9.55M

Top Sells

Rank Stock Value
1
RAPT
RAPT Therapeutics
RAPT
+$23

Sector Composition

Rank Sector Weight
1 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$65.7B
$144M 47.11%
2,142,684
+150,800
+8% +$9.55M
INDA icon
2
iShares MSCI India ETF
INDA
$6.81B
$135M 44.17%
2,425,144
– –
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.11B
$10M 3.28%
989,410
– –
FHTX icon
4
Foghorn Therapeutics
FHTX
$308M
$7.4M 2.42%
1,573,761
– –
PMVP icon
5
PMV Pharmaceuticals
PMVP
$70.4M
$2.79M 0.91%
2,627,643
– –
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$786B
$2.54M 0.83%
4,104
– –
ALEC icon
7
Alector
ALEC
$159M
$1.83M 0.6%
1,307,858
– –
SRZN icon
8
Surrozen
SRZN
$249M
$784K 0.26%
87,696
– –
RAPT
9
DELISTED
RAPT Therapeutics
RAPT
$658K 0.22%
82,234
-3
-0% -$23
TNYA icon
10
Tenaya Therapeutics
TNYA
$178M
$621K 0.2%
1,015,705
– –
SRZNW icon
11
Surrozen Inc Warrant
SRZNW
$3.09K ﹤0.01%
170,833
– –

Similar funds

WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $392M AUM 21.9% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BWM
Buckley Wealth Management Las Vegas, Nevada $392M AUM 28.21% 1-Year Est. Return
WSWA
Warren Street Wealth Advisors Newport Beach, California $393M AUM 23.31% 1-Year Est. Return
IPW
Inlet Private Wealth Jupiter, Florida $392M AUM 25.74% 1-Year Est. Return

Euclidean Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Euclidean Capital held 11 positions worth $306M, up 15% from $266M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital deployed $9.55M of net new capital in Q2 2025, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, up from 6.8% a quarter earlier.

On the sell side, the largest reduction was RAPT Therapeutics, an estimated $23 trimmed.

  • Euclidean Capital added most to Vanguard FTSE All-World ex-US ETF in Q2 2025, an estimated $9.55M increase.
  • Euclidean Capital's biggest Q2 2025 reduction was RAPT Therapeutics, cutting an estimated $23.
  • Euclidean Capital's ten largest holdings make up 100% of its $306M portfolio in Q2 2025.
  • Euclidean Capital opened 0 new positions and closed 0 in Q2 2025.
  • Euclidean Capital's portfolio value rose 15% quarter-over-quarter to $306M.

Based on Euclidean Capital's 13F filing for Q2 2025, filed 14 Aug 2025.